TY - JOUR A1 - Palm, Christoph A1 - Vieten, Andrea A1 - Salber, Dagmar A1 - Pietrzyk, Uwe T1 - Evaluation of Registration Strategies for Multi-modality Images of Rat Brain Slices JF - Physics in Medicine and Biology N2 - In neuroscience, small-animal studies frequently involve dealing with series of images from multiple modalities such as histology and autoradiography. The consistent and bias-free restacking of multi-modality image series is obligatory as a starting point for subsequent non-rigid registration procedures and for quantitative comparisons with positron emission tomography (PET) and other in vivo data. Up to now, consistency between 2D slices without cross validation using an inherent 3D modality is frequently presumed to be close to the true morphology due to the smooth appearance of the contours of anatomical structures. However, in multi-modality stacks consistency is difficult to assess. In this work, consistency is defined in terms of smoothness of neighboring slices within a single modality and between different modalities. Registration bias denotes the distortion of the registered stack in comparison to the true 3D morphology and shape. Based on these metrics, different restacking strategies of multi-modality rat brain slices are experimentally evaluated. Experiments based on MRI-simulated and real dual-tracer autoradiograms reveal a clear bias of the restacked volume despite quantitatively high consistency and qualitatively smooth brain structures. However, different registration strategies yield different inter-consistency metrics. If no genuine 3D modality is available, the use of the so-called SOP (slice-order preferred) or MOSOP (modality-and-slice-order preferred) strategy is recommended. KW - Histologie KW - Bildgebendes Verfahren KW - Schnittdarstellung KW - Multimodales Verfahren Y1 - 2009 U6 - https://doi.org/10.1088/0031-9155/54/10/021 VL - 54 IS - 10 SP - 3269 EP - 3289 ER - TY - JOUR A1 - Dammers, Jürgen A1 - Axer, Markus A1 - Gräßel, David A1 - Palm, Christoph A1 - Zilles, Karl A1 - Amunts, Katrin A1 - Pietrzyk, Uwe T1 - Signal enhancement in polarized light imaging by means of independent component analysis JF - NeuroImage N2 - Polarized light imaging (PLI) enables the evaluation of fiber orientations in histological sections of human postmortem brains, with ultra-high spatial resolution. PLI is based on the birefringent properties of the myelin sheath of nerve fibers. As a result, the polarization state of light propagating through a rotating polarimeter is changed in such a way that the detected signal at each measurement unit of a charged-coupled device (CCD) camera describes a sinusoidal signal. Vectors of the fiber orientation defined by inclination and direction angles can then directly be derived from the optical signals employing PLI analysis. However, noise, light scatter and filter inhomogeneities interfere with the original sinusoidal PLI signals. We here introduce a novel method using independent component analysis (ICA) to decompose the PLI images into statistically independent component maps. After decomposition, gray and white matter structures can clearly be distinguished from noise and other artifacts. The signal enhancement after artifact rejection is quantitatively evaluated in 134 histological whole brain sections. Thus, the primary sinusoidal signals from polarized light imaging can be effectively restored after noise and artifact rejection utilizing ICA. Our method therefore contributes to the analysis of nerve fiber orientation in the human brain within a micrometer scale. KW - Bildgebendes Verfahren KW - Polarisiertes Licht KW - Signalverarbeitung KW - Signaltrennung KW - Komponentenanalyse KW - Gehirn Y1 - 2010 U6 - https://doi.org/10.1016/j.neuroimage.2009.08.059 VL - 49 IS - 2 SP - 1241 EP - 1248 PB - Elsevier ER - TY - CHAP A1 - Pietrzyk, Uwe A1 - Palm, Christoph A1 - Beyer, Thomas T1 - Fusion strategies in multi-modality imaging T2 - Medical Physics, Vol 2. Proceedings of the jointly held Congresses: ICMP 2005, 14th International Conference of Medical Physics of the International Organization for Medical Physics (IOMP), the European Federation of Organizations in Medical Physics (EFOMP) and the German Society of Medical Physics (DGMP) ; BMT 2005, 39th Annual Congress of the German Society for Biomedical Engineering (DGBMT) within VDE ; 14th - 17th September 2005, Nuremberg, Germany KW - Bildgebendes Verfahren KW - Registrierung Y1 - 2005 SP - 1446 EP - 1447 ER - TY - GEN A1 - Weigert, Markus A1 - Palm, Christoph A1 - Quick, Harald H. A1 - Müller, Stefan P. A1 - Pietrzyk, Uwe A1 - Beyer, Thomas T1 - Template for MR-based attenuation correction for whole-body PET/MR imaging T2 - Nuklearmedizin KW - Kernspintomografie KW - Positronen-Emissions-Tomografie KW - Bildgebendes Verfahren KW - Schwächung Y1 - 2007 VL - 46 IS - 2 SP - A115 ER - TY - JOUR A1 - Hutterer, Markus A1 - Hattingen, Elke A1 - Palm, Christoph A1 - Proescholdt, Martin Andreas A1 - Hau, Peter T1 - Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients JF - Neuro-Oncology N2 - Despite multimodal treatment, the prognosis of high-grade gliomas is grim. As tumor growth is critically dependent on new blood vessel formation, antiangiogenic treatment approaches offer an innovative treatment strategy. Bevacizumab, a humanized monoclonal antibody, has been in the spotlight of antiangiogenic approaches for several years. Currently, MRI including contrast-enhanced T1-weighted and T2/fluid-attenuated inversion recovery (FLAIR) images is routinely used to evaluate antiangiogenic treatment response (Response Assessment in Neuro-Oncology criteria). However, by restoring the blood–brain barrier, bevacizumab may reduce T1 contrast enhancement and T2/FLAIR hyperintensity, thereby obscuring the imaging-based detection of progression. The aim of this review is to highlight the recent role of imaging biomarkers from MR and PET imaging on measurement of disease progression and treatment effectiveness in antiangiogenic therapies. Based on the reviewed studies, multimodal imaging combining standard MRI with new physiological MRI techniques and metabolic PET imaging, in particular amino acid tracers, may have the ability to detect antiangiogenic drug susceptibility or resistance prior to morphological changes. As advances occur in the development of therapies that target specific biochemical or molecular pathways and alter tumor physiology in potentially predictable ways, the validation of physiological and metabolic imaging biomarkers will become increasingly important in the near future. KW - High-grade glioma KW - Antiangiogenic treatment KW - MRI KW - PET KW - Multimodal response assessment KW - Gliom KW - Antiangiogenese KW - Bildgebendes Verfahren KW - Biomarker Y1 - 2015 U6 - https://doi.org/10.1093/neuonc/nou322 VL - 17 IS - 6 SP - 784 EP - 800 ER - TY - JOUR A1 - Becker, Johanna Sabine A1 - Matusch, Andreas A1 - Becker, Julia Susanne A1 - Wu, Bei A1 - Palm, Christoph A1 - Becker, Albert Johann A1 - Salber, Dagmar T1 - Mass spectrometric imaging (MSI) of metals using advanced BrainMet techniques for biomedical research JF - International Journal of Mass Spectrometry N2 - Mass spectrometric imaging (MSI) is a young innovative analytical technique and combines different fields of advanced mass spectrometry and biomedical research with the aim to provide maps of elements and molecules, complexes or fragments. Especially essential metals such as zinc, copper, iron and manganese play a functional role in signaling, metabolism and homeostasis of the cell. Due to the high degree of spatial organization of metals in biological systems their distribution analysis is of key interest in life sciences. We have developed analytical techniques termed BrainMet using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) imaging to measure the distribution of trace metals in biological tissues for biomedical research and feasibility studies—including bioaccumulation and bioavailability studies, ecological risk assessment and toxicity studies in humans and other organisms. The analytical BrainMet techniques provide quantitative images of metal distributions in brain tissue slices which can be combined with other imaging modalities such as photomicrography of native or processed tissue (histochemistry, immunostaining) and autoradiography or with in vivo techniques such as positron emission tomography or magnetic resonance tomography. Prospective and instrumental developments will be discussed concerning the development of the metalloprotein microscopy using a laser microdissection (LMD) apparatus for specific sample introduction into an inductively coupled plasma mass spectrometer (LMD-ICP-MS) or an application of the near field effect in LA-ICP-MS (NF-LA-ICP-MS). These nano-scale mass spectrometric techniques provide improved spatial resolution down to the single cell level. KW - Bioimaging KW - Brain tissue KW - Laser ablation inductively coupled plasma mass spectrometry KW - Laser microdissection inductively coupled plasma mass spectrometry KW - Metals KW - Metallomics KW - Nano-LA-ICP-MS KW - Tumour KW - Massenspektrometrie KW - Bildgebendes Verfahren KW - Metalle KW - Metallproteide KW - Gehirn Y1 - 2011 U6 - https://doi.org/10.1016/j.ijms.2011.01.015 VL - 307 IS - 1-3 SP - 3 EP - 15 PB - eLSEVIER CY - Elsevier ER - TY - GEN A1 - Scheppach, Markus W. A1 - Mendel, Robert A1 - Probst, Andreas A1 - Meinikheim, Michael A1 - Palm, Christoph A1 - Messmann, Helmut A1 - Ebigbo, Alanna T1 - Artificial Intelligence (AI) – assisted vessel and tissue recognition during third space endoscopy (Smart ESD) T2 - Zeitschrift für Gastroenterologie N2 - Clinical setting  Third space procedures such as endoscopic submucosal dissection (ESD) and peroral endoscopic myotomy (POEM) are complex minimally invasive techniques with an elevated risk for operator-dependent adverse events such as bleeding and perforation. This risk arises from accidental dissection into the muscle layer or through submucosal blood vessels as the submucosal cutting plane within the expanding resection site is not always apparent. Deep learning algorithms have shown considerable potential for the detection and characterization of gastrointestinal lesions. So-called AI – clinical decision support solutions (AI-CDSS) are commercially available for polyp detection during colonoscopy. Until now, these computer programs have concentrated on diagnostics whereas an AI-CDSS for interventional endoscopy has not yet been introduced. We aimed to develop an AI-CDSS („Smart ESD“) for real-time intra-procedural detection and delineation of blood vessels, tissue structures and endoscopic instruments during third-space endoscopic procedures. Characteristics of Smart ESD  An AI-CDSS was invented that delineates blood vessels, tissue structures and endoscopic instruments during third-space endoscopy in real-time. The output can be displayed by an overlay over the endoscopic image with different modes of visualization, such as a color-coded semitransparent area overlay, or border tracing (demonstration video). Hereby the optimal layer for dissection can be visualized, which is close above or directly at the muscle layer, depending on the applied technique (ESD or POEM). Furthermore, relevant blood vessels (thickness> 1mm) are delineated. Spatial proximity between the electrosurgical knife and a blood vessel triggers a warning signal. By this guidance system, inadvertent dissection through blood vessels could be averted. Technical specifications  A DeepLabv3+ neural network architecture with KSAC and a 101-layer ResNeSt backbone was used for the development of Smart ESD. It was trained and validated with 2565 annotated still images from 27 full length third-space endoscopic videos. The annotation classes were blood vessel, submucosal layer, muscle layer, electrosurgical knife and endoscopic instrument shaft. A test on a separate data set yielded an intersection over union (IoU) of 68%, a Dice Score of 80% and a pixel accuracy of 87%, demonstrating a high overlap between expert and AI segmentation. Further experiments on standardized video clips showed a mean vessel detection rate (VDR) of 85% with values of 92%, 70% and 95% for POEM, rectal ESD and esophageal ESD respectively. False positive measurements occurred 0.75 times per minute. 7 out of 9 vessels which caused intraprocedural bleeding were caught by the algorithm, as well as both vessels which required hemostasis via hemostatic forceps. Future perspectives  Smart ESD performed well for vessel and tissue detection and delineation on still images, as well as on video clips. During a live demonstration in the endoscopy suite, clinical applicability of the innovation was examined. The lag time for processing of the live endoscopic image was too short to be visually detectable for the interventionist. Even though the algorithm could not be applied during actual dissection by the interventionist, Smart ESD appeared readily deployable during visual assessment by ESD experts. Therefore, we plan to conduct a clinical trial in order to obtain CE-certification of the algorithm. This new technology may improve procedural safety and speed, as well as training of modern minimally invasive endoscopic resection techniques. KW - Artificial Intelligence KW - Medical Image Computing KW - Endoscopy KW - Bildgebendes Verfahren KW - Medizin KW - Künstliche Intelligenz KW - Endoskopie Y1 - 2022 U6 - https://doi.org/10.1055/s-0042-1755110 VL - 60 IS - 08 PB - Georg Thieme Verlag CY - Stuttgart ER -